Reducing Colorectal Cancer Incidence and Disparities: Performance and Outcomes of a Screening Colonoscopy Program in South Carolina

Table 1

SCOPE SC program performance in year 1: efficiency of patient recruitment, effectiveness of procedure performance, and patient safety.

Performance indicator	Number/%
Program efficiency
Program target number of colonoscopy screenings (funding available)	800
Number of eligible beneficiaries identified	782
Number of who completed colonoscopy	665
% of eligible beneficiaries navigated through procedure completion	85%
Number of performing physicians	32
Bowel preparation status documented (benchmark 100%) [12]	98.5%
Patient safety: adverse event rate (benchmark 2%, all event types) [12]	0.9%*
Procedure performance quality
Cecal intubation rate (benchmark 95%) [12]	98.9%
Bowel preparation status rated fair, good, or excellent	92.1%
Proportion of screened persons with polyp(s)	56.4%
Proportion of polyps completely removed	93.1%**
Proportion of polyps retrieved for pathology exam (benchmark 95%) [11]	99.9%
Polyp, adenoma, and cancer detection
Proportion of screened persons with polyp(s)	56.4%**
Proportion of screened persons with hyperplastic polyp(s)	34.6%**
Proportion of screened persons with adenoma(s) found (ADR) (benchmark 15% for women and 25% for men) [12]	27.8%
Proportion with advanced neoplasm removed (cancer and polyps at imminent risk of cancer)	7.7%**
Diagnosed with colorectal cancer	3 (0.45%)
Total number of polyps removed	917
Total number of adenomas removed	338
Total number of advanced neoplasms removed	58

Advanced neoplasms include adenomas ≥10 mm in diameter, adenomas with villous or tubule villous features or high-grade dysplasia, and cancer or carcinoid tumor.
^∗𝑛=6 (1) bleeding, (2) incomplete colonoscopy due to torsion, and (3) unspecified but having good bowel preparation and the procedure was completed, no perforations.
**No national quality benchmarks exist for these indicators.